Abstract
The symptoms of nausea and vomiting during pregnancy (NVP) are a clinically significant condition, capable of affecting more than 80% of pregnant women, interfering with the quality of life, and can lead to psychosocial impacts. Ondansetron, a highly selective 5HT-3 serotonin receptor antagonist, is used in the prevention and treatment of nausea and vomiting in general, induced by chemoth…